HomeCompareMDVL vs KMB

MDVL vs KMB: Dividend Comparison 2026

MDVL yields 111.11% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MDVL wins by $6.03M in total portfolio value
10 years
MDVL
MDVL
● Live price
111.11%
Share price
$1.80
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.07M
Annual income
$2,192,447.17
Full MDVL calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.35
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,222.34
Full KMB calculator →

Portfolio growth — MDVL vs KMB

📍 MDVL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMDVLKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MDVL + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MDVL pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDVL
Annual income on $10K today (after 15% tax)
$9,444.44/yr
After 10yr DRIP, annual income (after tax)
$1,863,580.09/yr
KMB
Annual income on $10K today (after 15% tax)
$446.39/yr
After 10yr DRIP, annual income (after tax)
$4,438.99/yr
At 15% tax rate, MDVL beats the other by $1,859,141.11/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDVL + KMB for your $10,000?

MDVL: 50%KMB: 50%
100% KMB50/50100% MDVL
Portfolio after 10yr
$3.06M
Annual income
$1,098,834.75/yr
Blended yield
35.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

MDVL
No analyst data
Altman Z
-14.7
Piotroski
4/9
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.7% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDVL buys
0
KMB buys
0
No recent congressional trades found for MDVL or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMDVLKMB
Forward yield111.11%5.25%
Annual dividend / share$2.00$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17%
Portfolio after 10y$6.07M$45.9K
Annual income after 10y$2,192,447.17$5,222.34
Total dividends collected$5.48M$21.6K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: MDVL vs KMB ($10,000, DRIP)

YearMDVL PortfolioMDVL Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$21,811$11,111.11$11,314$614.45+$10.5KMDVL
2$45,987$22,649.13$12,867$760.19+$33.1KMDVL
3$93,836$44,629.82$14,713$945.27+$79.1KMDVL
4$185,513$85,108.97$16,924$1,181.90+$168.6KMDVL
5$355,752$157,252.56$19,596$1,486.64+$336.2KMDVL
6$662,484$281,829.11$22,850$1,882.16+$639.6KMDVL
7$1,199,347$490,489.82$26,849$2,399.80+$1.17MMDVL
8$2,113,183$829,881.38$31,812$3,083.36+$2.08MMDVL
9$3,627,652$1,366,546.40$38,033$3,994.72+$3.59MMDVL
10$6,074,035$2,192,447.17$45,918$5,222.34+$6.03MMDVL

MDVL vs KMB: Complete Analysis 2026

MDVLStock

MedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, kiosk, and drive-thru solutions in the United States and Canada. It operates in two segments, Retail Pharmacy Services and Pharmacy Technology. The company's MedCenter enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio-visual connection to a live pharmacist enabling prescription drug dispensing to occur directly to a patient with real-time supervision by a pharmacist. It also owns and operates SpotRx, a retail pharmacy platform. As of December 31, 2021, the company had 81 MedCenter kiosks. MedAvail Holdings, Inc. is headquartered in Mississauga, Canada.

Full MDVL Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this MDVL vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDVL vs SCHDMDVL vs JEPIMDVL vs OMDVL vs KOMDVL vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.